Santa Clara, CA 4/6/07; La Jolla, CA 4/6/07—Agilent Technologies has signed a definitive agreement to purchase Stratagene for $10.94 per share of common stock, a 28% premium over Stratagene’s April 5 closing prices, or approximately $246.2 million in cash. Stratagene’s products include reagents and instruments for life science research and clinical diagnostics. “We see Stratagene’s […]

NanoAndMore USA opened a West Coast office in Portland, Oregon in December 2006. BudgetSensors, a manufacturer of silicon and silicon nitride probes for atomic force microscopes (AFM), named NanoAndMore USA its exclusive North American distributor. Oxford Instruments NanoAnalysis America was named Kleindiek Nanotechnik’s North American sales and service representatives for micro- and nano-manipulation systems for […]

The National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), will be granting $23 million a year for seven years to establish six Centers of Excellence for Influenza Research and Surveillance. The Centers of Excellence are located at the following institutions: St. Jude Children’s Hospital, UCLA, the […]

Micronic BV introduced VolumeCheck for the determination of sample volumes in unsealed 96-well microplates, 96-tube racks and high-volume test tube racks. CyBio AG introduced the new-generation CyBi-Well vario, which allows liquid transfer from 25 nL to 250 µL. Tecan introduced the HID EVOlution Systems for the analysis of forensic DNA casework samples. It integrates Tecan’s […]

Venlo, The Netherlands 4/13/07—QIAGEN NV has agreed to acquire eGene, the maker of the HAD-GT12 Genetic Analyzer, an capillary electrophoresis–based system for DNA analysis in research and molecular diagnostics applications. QIAGEN North American Holdings will offer $0.65 in cash and 0.0416 common shares of QIAGEN stock per eGene share for an aggregate amount of approximately […]

Waltham, MA 4/2/07—PerkinElmer has purchased Improvision, a UK-based provider of cellular imaging software and integrated hardware solutions, including the Volocity 3D and 4D imaging software. Improvision generated 2006 revenues of approximately £6 million ($11.1 million). “This acquisition strengthens our leading capability in the fast-growing field of advanced cellular sciences,” commented PerkinElmer Chairman and CEO Gregory […]

Washington, DC 3/30/07; Waltham, MA 4/3/07; Portland, OR 4/4/07—The US Federal Trade Commission has approved Thermo Fisher Scientific’s sale of its Genevac business to Riverlake Equity Partners (see IBO 2/15/07). Genevac will merge with SP Industries, another Riverlake company, and SP Industries CEO Charles L. Grant will lead Genevac operations. Terms were not disclosed.